Exagen (XGN)
(Delayed Data from NSDQ)
$1.38 USD
-0.02 (-1.43%)
Updated Apr 24, 2024 03:42 PM ET
3-Hold of 5 3
C Value A Growth C Momentum A VGM
Industry / Sector Report
Industry : Medical - Products
Zacks Industry Rank
Bottom 40% (152 out of 252)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.33 | 1.69 | 9.99 |
Current Quarter Estimate | -0.40 | 5.88 | 60.00 |
Year Ago Quarter Estimate | -0.44 | 4.88 | 52.54 |
Next Quarter Estimate | -0.37 | 7.06 | 61.00 |
Next Year Estimate | -1.03 | 39.92 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -8.96 | 18.30 | 17.08 |
Next Year | 29.45 | 25.30 | 8.00 |
Last 5 Years | NA | 3.70 | 8.10 |
Next 5 Years | NA | 10.90 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -13.85 |
Price/Book (MRQ) | 1.05 | 1.94 |
Price/Cash Flow (MRFY) | NA | 10.82 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -45.08% | 0.17% |
Return on Equity (TTM) | -80.28% | 8.53% |
Debt to Equity (MRQ) | NA | 22.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.